Title: McMillin DW, Delmore J, Negri J et al. Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications. Br J Haematol. 2011 Feb;152(4):420-32.
1431697-85-6
844442-38-2
902135-91-5
902135-89-1
936940-11-3 | (1-Benzyl-1h-pyrazol-4-yl)methanamine | AA00GU6Y | MFCD01175727
914223-27-1 | tert-Butyl 2-cyano-2-(5-nitropyridin-2-yl)acetate | AA00GUAW | MFCD09033813
929974-03-8 | 2-(1-Methyl-1H-imidazol-2-yl)-1-phenylethanone oxime | AA00GUE5 | MFCD08691267
90004-94-7 | 1-(4-Bromo-2-nitrophenyl)ethanone | AA00GUMF | MFCD11977406
914610-39-2 | 1-Methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzenesulfonyl]-piperazine | AA00GUUC | MFCD09746210
902835-85-2 | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)nicotinic acid | AA00GV94 | MFCD06245542
898403-15-1 | 2-Methyl-2-(pyrrolidin-1-yl)propanoic acid | AA00GVEM | MFCD05230475
938458-92-5 | 1-(3,4-Dimethylbenzyl)piperazin-2-one | AA00GVJL | MFCD09055234
936940-54-4 | 3-(2-Aminophenyl)-1,3-oxazolidin-2-one | AA00GVNV | MFCD09055390
915922-93-9 | 5-(Tetrahydro-2h-pyran-2-yl)thiophene-2-carbaldehyde | AA00GVS9 | MFCD08059923
